Strata Skin Sciences, Inc. (SSKN) Sees Unusually-High Trading Volume

Shares of Strata Skin Sciences, Inc. (NASDAQ:SSKN) saw unusually-high trading volume on Tuesday . Approximately 148,300 shares changed hands during trading, an increase of 24% from the previous session’s volume of 119,286 shares.The stock last traded at $1.20 and had previously closed at $1.14.

SSKN has been the topic of a number of recent analyst reports. HC Wainwright set a $12.00 price target on Strata Skin Sciences and gave the company a “buy” rating in a report on Wednesday, October 18th. Zacks Investment Research cut Strata Skin Sciences from a “hold” rating to a “sell” rating in a report on Wednesday, August 16th. Finally, ValuEngine cut Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a report on Monday, October 2nd.

The company has a debt-to-equity ratio of 1.85, a quick ratio of 0.93 and a current ratio of 1.34.

TRADEMARK VIOLATION WARNING: “Strata Skin Sciences, Inc. (SSKN) Sees Unusually-High Trading Volume” was reported by Markets Daily and is owned by of Markets Daily. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/15/strata-skin-sciences-inc-sskn-sees-unusually-high-trading-volume.html.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply